Peptide Receptor Radionuclide Therapy (PRRT) in a Patient Affected by Metastatic Breast Cancer with Neuroendocrine Differentiation-Reference-Cited by-同舟云学术

Peptide Receptor Radionuclide Therapy (PRRT) in a Patient Affected by Metastatic Breast Cancer with Neuroendocrine Differentiation

Published:2012 Issue:5 Volume:7 Page:408-410
ISSN:1661-3791
Container-title:Breast Care
language:en
Short-container-title:Breast Care

Author:

Savelli Giordano,Zaniboni Alberto,Bertagna Francesco,Bosio Giovanni,Nisa Lutfun,Rodella Carlo,Biasiotto Giorgio,Bettinsoli Giovanni,Migliorati Elena,Peli Alessia,Falchi Roberta,Giuffrida Francesca,Giubbini Raffaele

Publisher

S. Karger AG

Subject

Oncology,Surgery

Reference15 articles.

1. The relationship between somatostatin, epidermal growth factor, and steroid hormone receptors in breast cancer

2. Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: Relationship to egf receptors

3. Somatostatin-receptor scintigraphy in primary breast cancer

4. ¹¹¹ln-Octreotide Scintigraphy in Oncology

5. Somatostatin receptor subtypes sst1, sst2, sst3 and sst5expression in human pituitary, gastroentero-pancreatic and mammary tumors

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroendocrine neoplasms of the breast: a review of literature;Virchows Archiv;2024-07-09

2. Le neoplasie neuroendocrine della mammella: inquadramento diagnostico e gestione clinica;L'Endocrinologo;2024-06

3. Visual and whole-body quantitative analyses of 68 Ga-DOTATATE PET/CT for prognosis of outcome after PRRT with 177Lu-DOTATATE;Annals of Nuclear Medicine;2024-01-22

4. Seltene Malignome der Brust;Die Gynäkologie;2023-12-13

5. Theranostics in breast cancer;Frontiers in Nuclear Medicine;2023-08-04